Clinical Trials Browser

carfilzomib × Head & Neck × Clear all

NCT02047253 2018-12-19

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Phase 2 Completed

28 enrolled 12 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms